📣 VC round data is live. Check it out!

Gradiant Valuation Multiples

Discover revenue and EBITDA valuation multiples for Gradiant and similar public comparables like SRP Groupe, Upexi, Kurashicom, Hour Loop and more.

Gradiant Overview

About Gradiant

Gradiant Corp operates in the retail domain in Korea. Its principal business comprises managing internet-based shopping sites. The company, through its website, sells a range of products including beauty products, fashion wear, household appliances, and food products.


Founded

1997

HQ

South Korea

Employees

N/A

Financials (FY)

Revenue: $2B
EBITDA: $20M

EV

$13M

Valuation Multiples

Start free trial

Valuation Multiples for 15K+ Public Comps

AdidasAirbnbAmazonCiscoCoca-ColaDellDropboxIBMIntelMcDonaldsNikeNVIDIASamsungSpotifyTeslaToyota
Browse Valuation Multiples

Gradiant Financials

Gradiant reported last fiscal year revenue of $2B and EBITDA of $20M.

In the same fiscal year, Gradiant generated $111M in gross profit, $20M in EBITDA, and had net loss of ($24M).


Gradiant P&L

In the most recent fiscal year, Gradiant reported revenue of $2B and EBITDA of $20M.

Gradiant is unprofitable as of last fiscal year, with gross margin of 5%, EBITDA margin of 1%, and net margin of (1%).

See analyst estimates for Gradiant
Last FY202320242025202620272028
Revenue$2B$2B$2B$2B
Gross Profit$111M$106M$107M$111M
Gross Margin5%5%5%5%
EBITDA$20M$28M$30M$20M
EBITDA Margin1%1%1%1%
EBIT Margin(1%)0%(0%)(1%)
Net Profit($24M)($11M)($28M)($24M)
Net Margin(1%)(0%)(1%)(1%)

Financial data powered by Morningstar, Inc.

Gradiant Stock Performance

Gradiant has current market cap of $92M, and enterprise value of $13M.


Gradiant's stock price is $7.94.

Gradiant has an EPS (earnings per share) of $-2.11.

See more trading valuation data for Gradiant
EVMarket CapPrice 1DPrice 1MPrice 3MPrice 12MEPS
$13M$92M-0.4%$-2.11

Benchmark Trading Valuation Multiples by Industry

Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.

Start Free Trial

Gradiant Valuation Multiples

Gradiant trades at 0.0x EV/Revenue multiple, and 0.6x EV/EBITDA.

See NTM and 2027E valuation multiples for Gradiant

Gradiant Financial Valuation Multiples

As of May 10, 2026, Gradiant has market cap of $92M and EV of $13M.

Gradiant has a P/E ratio of (3.8x).

Last FY202320242025202620272028
EV/Revenue0.0x0.0x0.0x0.0x
EV/EBITDA0.6x0.4x0.4x0.6x
EV/EBIT(0.6x)6.3x(3.3x)(0.6x)
EV/Gross Profit0.1x0.1x0.1x0.1x
P/E(3.8x)(8.5x)(3.3x)(3.8x)
EV/FCF(1.8x)(2.9x)(0.4x)(1.8x)

Multiples above and below 250x are considered non-meaningful (n/m). Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Verified Gradiant Valuation Multiples

Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.

FactSetMorningstar
Start Free Trial

Gradiant Margins & Growth Rates

In the most recent fiscal year, Gradiant reported gross margin of 5%, EBITDA margin of 1%, and net margin of (1%).

See estimated margins and future growth rates for Gradiant

Gradiant Margins

Last FY20242025202720282029
Gross Margin5%5%5%
EBITDA Margin1%1%1%
EBIT Margin(1%)(0%)(1%)
Net Margin(1%)(1%)(1%)
FCF Margin(0%)(1%)(0%)

Gradiant Growth Rates

23/2424/2526/2727/2828/29
Revenue Growth(3%)(8%)
Gross Profit Growth2%3%
EBITDA Growth7%(34%)
EBIT Growth(288%)434%
Net Profit Growth155%(11%)
FCF Growth623%(77%)

Data powered by FactSet, Inc. and Morningstar, Inc.

Gradiant Operational KPIs

Access forward-looking KPIs for Gradiant
Last FY202320242025202620272028
S&M Expenses to Revenue1%0%1%1%
G&A Expenses to Revenue1%1%1%1%
R&D Expenses to Revenue0%0%0%0%
Opex to Revenue6%4%5%6%

Data powered by FactSet, Inc. and Morningstar, Inc.

Valuation Multiples Across 230+ Verticals

Gradiant Competitors

Gradiant competitors include SRP Groupe, Upexi, Kurashicom, Hour Loop, Answear.com, 09Women, MARX Biotech, Raccoon Holdings, Aromatica Co and Pierce Group.

Most Gradiant public comparables operate across Consumer E-commerce and Horizontal E-commerce.

EV/RevenueEV/EBITDA
Last FYLTM2027ELast FYLTM2027E
SRP Groupe0.1x0.1x(16.8x)(3.3x)
Upexi19.3x25.2x(25.2x)
Kurashicom1.2x1.2x8.4x8.4x
Hour Loop0.6x31.1x
Answear.com0.3x0.3x9.7x8.4x
09Women2.2x8.8x
MARX Biotech5.5x38.2x
Raccoon Holdings1.5x1.5x7.0x

This data is available for Pro users. Sign up to see all Gradiant competitors and their valuation data.

Start Free Trial

Gradiant Investment Activity

Gradiant has invested in 1 company to date.

Latest investment by Gradiant was on April 23rd 2025. Gradiant invested in Grove Biopharma in their $30M Series A round (EV/Revenue multiple of ).

See VC round multiples

Latest Investments by Gradiant

Grove Biopharma
Description
Grove Biopharma is an Australian biotechnology company developing protein-like polymers for peptide drug delivery. Its materials science platform targets chronic inflammation and neurodegeneration diseases like Alzheimer's. Candidates enhance stability and bioavailability of therapeutics. Operating from grovebiopharma.com, it advances preclinical programs for unmet needs.
HQ CountryUnited States
HQ City
Chicago, IL
Deal Date23 Apr 2025
RoundSeries A
Raised$30M
InvestorsDCVC Bio; Eli Lilly; Gradiant corporation; InVivium Capital; Mansueto Investments; Walder Ventures
Valuationundisclosed
EV/Revenue
EV/EBITDA

This data is available for Pro users. Sign up to see all Gradiant investments and their VC round multiples.

Start Free Trial

Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples

Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.

Start Free Trial

About Gradiant

When was Gradiant founded?Gradiant was founded in 1997.
Where is Gradiant headquartered?Gradiant is headquartered in South Korea.
Is Gradiant publicly listed?Yes, Gradiant is a public company listed on Korea Exchange.
What is the stock symbol of Gradiant?Gradiant trades under 035080 ticker.
When did Gradiant go public?Gradiant went public in 1999.
Who are competitors of Gradiant?Gradiant main competitors include SRP Groupe, Upexi, Kurashicom, Hour Loop, Answear.com, 09Women, MARX Biotech, Raccoon Holdings, Aromatica Co, Pierce Group.
What is the current market cap of Gradiant?Gradiant's current market cap is $92M.
What is the current revenue of Gradiant?Gradiant's last fiscal year revenue is $2B.
What is the current EV/Revenue multiple of Gradiant?Current revenue multiple of Gradiant is 0.0x.
Is Gradiant profitable?No, Gradiant is not profitable.
How many companies Gradiant has acquired to date?Gradiant hasn't acquired any companies yet (or none have been disclosed publicly).
In how many companies Gradiant has invested to date?As of May 2026, Gradiant has invested in 1 company.
What was the last Gradiant investment?On 23rd April 2025 Gradiant invested in Grove Biopharma, participating in a $30M Series A round, alongside DCVC Bio, Eli Lilly, Gradiant corporation, InVivium Capital, Mansueto Investments, and Walder Ventures.
In what companies Gradiant invested in?Gradiant invested in Grove Biopharma.

See public comps similar to Gradiant

Lists including Gradiant

Start Your
Free Trial Today

Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.

Start Trial